ADMA Biologics Q3 EPS $(0.19) Up From $(0.33) YoY, Sales $7.2M Up From $4.23M YoY

ADMA Biologics (NASDAQ:ADMA) reported quarterly losses of $(0.19) per share. This is a 42.42 percent increase over losses of $(0.33) per share from the same period last year. The company reported $7.2 million in sales

Benzinga · 11/06/2019 22:35

ADMA Biologics (NASDAQ:ADMA) reported quarterly losses of $(0.19) per share. This is a 42.42 percent increase over losses of $(0.33) per share from the same period last year. The company reported $7.2 million in sales this quarter. This is a 70.21 percent increase over sales of $4.23 million the same period last year.